Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | RDW | Class A Ordinary Shares | Purchase | $200K | +19.4K | +0.76% | $10.32 | 2.57M | Jul 13, 2021 | See Notes 1 and 2 | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | RDW | Warrant | Purchase | $28.6K | +9.7K | +0.76% | $2.94 | 1.29M | Jul 13, 2021 | Class A Ordinary Shares | 9.7K | $11.50 | See Notes 1 and 2 | F1, F2, F3, F4 |
Id | Content |
---|---|
F1 | The reporting persons are Crescent Park Management, L.P. ("Crescent Park"), Crescent Park GP, LLC ("Crescent Park GP") and Eli D. Cohen. Crescent Park is the investment adviser of investment funds (the "Funds"), and Crescent Park GP is the general partner of the Funds. Mr. Cohen is the control person of Crescent Park and Crescent Park GP. Crescent Park is filing this report for itself and the other reporting persons. The reporting persons are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934. |
F2 | The Funds hold the securities reported herein directly for the benefit of their investors. Crescent Park and Crescent Park GP indirectly beneficially own the securities reported herein as the investment adviser and general partner, respectively, of the Funds. Mr. Cohen indirectly beneficially owns the securities reported herein as the control person of Crescent Park and Crescent Park GP. The reporting persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest in them. |
F3 | The warrants will become exercisable on the later of 30 days after the completion of the Issuer's initial business combination and November 27, 2021. |
F4 | The warrants will expire five years after the completion of the Issuer's initial business combination or earlier upon redemption of the warrants or liquidation of the Issuer. |